Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-01 Sale |
2022-11-03 5:30 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20.03 | $250,355 | 1,778,523 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:36 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $20.05 | $200,473 | 304,401 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:32 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
10,000 | $20.03 | $200,315 | 7,394,527 (Indirect) |
View |
| 2022-10-03 Sale |
2022-10-05 4:25 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $19.99 | $199,852 | 2,279,338 (Indirect Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 4:22 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20.05 | $250,646 | 1,791,023 (Indirect Direct) |
View |
| 2022-09-21 Sale |
2022-09-22 4:00 pm |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
613,603 | $18.55 | $11,380,779 | 8,464,301 (Direct) |
View |
| 2022-09-21 Sale |
2022-09-22 4:00 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
613,603 | $18.55 | $11,380,779 | 8,904,527 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 6:05 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
340,702 | $20.44 | $6,963,116 | 9,517,624 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 5:47 pm |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
340,702 | $20.44 | $6,963,116 | 9,077,904 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:53 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
245,039 | $23.76 | $5,823,084 | 9,858,326 (Indirect) |
View |
| 2022-09-13 Sale |
2022-09-15 7:48 pm |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
245,039 | $23.76 | $5,823,084 | 9,418,606 (Direct) |
View |
| 2022-09-02 Sale |
2022-09-15 1:21 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
5,000 | $23.82 | $119,108 | 10,103,365 (Indirect) |
View |
| 2022-09-01 Sale |
2022-09-06 7:54 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $23.25 | $232,484 | 314,401 (Direct) |
View |
| 2022-09-01 Sale |
2022-09-06 7:52 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
5,000 | $23.27 | $116,358 | 10,108,365 (Indirect) |
View |
| 2022-09-01 Sale |
2022-09-06 7:51 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $23.25 | $232,452 | 2,289,338 (Indirect Direct) |
View |
| 2022-09-01 Sale |
2022-09-06 7:50 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $23.25 | $290,581 | 1,803,523 (Indirect Direct) |
View |
| 2022-09-01 Sale |
2022-09-06 7:49 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $23.25 | $290,581 | 1,803,523 (Indirect Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 7:25 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
941 | $24.31 | $22,876 | 2,314,777 (Indirect Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 7:24 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
4,003 | $24.31 | $97,313 | 1,862,337 (Indirect Direct) |
View |
| 2022-08-16 Sale |
2022-08-17 7:23 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
1,089 | $24.31 | $26,474 | 342,276 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-08 8:03 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
10,000 | $20 | $200,004 | 10,113,365 (Indirect) |
View |
| 2022-08-04 Sale |
2022-08-05 5:20 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
10,000 | $20.05 | $200,541 | 321,365 (Direct) |
View |
| 2022-08-04 Sale |
2022-08-05 5:19 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
12,500 | $20 | $250,021 | 1,809,340 (Indirect Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 6:57 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $16.88 | $168,810 | 2,296,718 (Indirect Direct) |
View |
| 2022-07-18 Sale |
2022-07-20 6:18 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
2,500 | $20 | $50,000 | 331,365 (Direct) |
View |
| 2022-07-18 Sale |
2022-07-20 6:17 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
2,600 | $20 | $52,001 | 10,123,365 (Indirect) |
View |
| 2022-07-18 Sale |
2022-07-20 6:17 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
2,600 | $20 | $52,003 | 1,821,840 (Indirect Direct) |
View |
| 2022-07-01 Sale(A) |
2022-07-12 9:14 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
1,800 | $20 | $36,000 | 10,127,207 (Indirect) |
View |
| 2022-07-08 Sale |
2022-07-12 7:52 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
1,242 | $20 | $24,840 | 10,125,965 (Indirect) |
View |
| 2022-07-08 Sale |
2022-07-12 7:31 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
1,416 | $20 | $28,320 | 333,865 (Direct) |
View |
| 2022-07-08 Sale |
2022-07-12 7:30 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
1,795 | $20 | $35,900 | 1,824,440 (Indirect Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 9:00 pm |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
2,279 | $20 | $45,580 | 335,281 (Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 8:58 pm |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
1,800 | $20 | $36,000 | 463,200 (Indirect) |
View |
| 2022-07-01 Sale |
2022-07-06 8:57 pm |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
10,000 | $18.72 | $187,158 | 2,306,718 (Indirect Direct) |
View |
| 2022-07-01 Sale |
2022-07-06 8:56 pm |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
2,603 | $20 | $52,060 | 1,826,235 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-21 Other |
2022-09-22 4:00 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Canaan XI L.P. Canaan Partners XI LLC 10% Owner |
1,500,000 | $0 | 8,464,301 (Direct) |
View |
| 2022-09-21 Other |
2022-09-22 4:00 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Grant Julie Papanek Director |
1,500,000 | $0 | 8,904,527 (Indirect) |
View |
| 2022-09-19 Other |
2022-09-21 4:58 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Fund XI L.P. 10% Owner |
600,854 | $0 | 7,210,242 (Direct) |
View |
| 2022-09-12 Option Award |
2022-09-14 7:34 pm |
N/A 2032-09-11 |
Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director |
33,900 | $0 | 33,900 (Direct) |
View |
Ownership |
2022-09-14 7:32 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Nicholson Garry A Director |
0 | $0 | 0 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 7:25 pm |
N/A 2032-01-17 |
Day One Biopharmaceuticals Inc. | DAWN | Blackman Samuel C. Chief Medical Officer |
3,561 | $0 | 2,314,777 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 7:24 pm |
N/A 2032-01-17 |
Day One Biopharmaceuticals Inc. | DAWN | Bender Jeremy Chief Executive Officer |
10,686 | $0 | 1,862,337 (Direct) |
View |
| 2022-08-15 Exercise |
2022-08-17 7:23 pm |
N/A 2032-01-17 |
Day One Biopharmaceuticals Inc. | DAWN | York Charles N II COO, CFO and Secretary |
4,125 | $0 | 342,276 (Direct) |
View |
Ownership |
2022-07-12 9:14 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
0 | $0 | 10,129,007 (Indirect) |
View |
| 2021-11-03 Ownership |
2022-07-12 9:14 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Grant Papanek Julie Director |
465,000 | $0 | 10,129,007 (Direct) |
View |
| 2022-07-01 Other |
2022-07-06 4:42 pm |
N/A N/A |
Day One Biopharmaceuticals Inc. | DAWN | Atlas Venture Opportunity Fund I L.P. 10% Owner |
198,280 | $0 | 991,396 (Direct) |
View |